Investor Presentaiton
OPERATING PERFORMANCE DEVELOPMENT
ACROSS PRIVATE LARGE PORTFOLIO COMPANIES (CONT'D)
80
RETAIL (PHARMACY)
REVENUE DEVELOPMENT
+26.3%
+16.9%
EBITDA¹ DEVELOPMENT
KEY DRIVERS
Scheduled expansion of the retail
(pharmacy) chain, rebounding
demand for retail products and an
overall improvement of economic
activities have positively impacted
the performance of the business.
Same-store growth rate up 31.9 ppts
y-o-y to 26.3% in 2Q21.
Number of bills issued up 25.7% y-o-
y to 7.2 million in 2Q21.
Average bill size up 5.4% y-o-y to
GEL 18.5 in 2Q21.
Georgia Capital PLC | 1. Excluding IFRS 16.
GEL MILLION
319
+33.2%
295
+38.4%
149
144
199
373
+31.3%
15
15
+33.9%
20
20
+7.5%
34
31
GEORGIA
CAPITAL
-1.2%
33
33
2Q19
2Q20
2Q21
1H19
1H20
1H21
2Q19
2Q20
2Q21
1H19
1H20
1H21
36View entire presentation